Literature DB >> 22311035

Association between MTHFR C677T polymorphism and osteonecrosis of the femoral head: a meta-analysis.

Xi-fu Shang1, Hong Su, Wei-wei Chang, Chen-cheng Wang, Qin Han, Zhi-wei Xu.   

Abstract

The results of studies on association between the C677T polymorphism of the 5,10-methylene-tetrahydrofolate reductase (MTHFR) gene and osteonecrosis of the femoral head (ONFH) are controversial. To derive a more precise estimation of the relationship between the MTHFR C677T polymorphism and ONFH, a meta-analysis was performed. Eight studies on MTHFR C677T association with ONFH were searched up to April 2011, and the genotype frequencies in control group were consistent with Hardy-Weinberg equilibrium. The effect summary odds ratio (OR) and 95% confidence intervals were obtained. Publication bias was tested by funnel plot, Egger's regression test, and heterogeneity was assessed. Eight studies containing 778 cases and 1,162 controls were included. Heterogeneity was observed (χ(2) = 18.58, P = 0.01). Under the random effects model, the common OR was 1.38 (95% CI: 0.92-2.08; P = 0.12). In the subgroup meta-analysis, there was an association between MTHFR C677T polymorphism and ONFH in non-Asian population for CT + TT vs. CC (OR = 1.72; 95% CI: 1.21-2.43; P = 0.002; I(2) = 37.9%, P = 0.17), but not for Asian population (OR = 0.88; 95% CI: 0.66-1.66; P = 0.35; I(2) = 45.4%, P = 0.16). There was heterogeneity between studies and no clear evidence of an association on a worldwide population. When stratifying for the race, this meta-analysis did not provide an evidence of confirming association between MTHFR C677T polymorphism and ONFH. The large sample and well-designed study based on different ethnic groups should be considered in future associated studies to clarify the association of MTHFR C677T polymorphism with ONFH susceptibility.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22311035     DOI: 10.1007/s11033-012-1540-0

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  29 in total

1.  The 677C-->T mutation of the methylene-tetrahydrofolate reductase gene in the pathogenesis of osteonecrosis of the femoral head.

Authors:  Charalampos G Zalavras; Konstantinos N Malizos; Eleni Dokou; George Vartholomatos
Journal:  Haematologica       Date:  2002-01       Impact factor: 9.941

2.  Severe protein C deficiency and aseptic osteonecrosis of the hip joint: a case report.

Authors:  C Wermes; F Bergmann; B Reller; K W Sykora
Journal:  Eur J Pediatr       Date:  1999-12       Impact factor: 3.183

3.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

4.  Lack of association of MTHFR gene polymorphisms with the risk of osteonecrosis of the femoral head in a Korean population.

Authors:  Tae-Ho Kim; Jung Min Hong; Hyun-Ju Kim; Eui Kyun Park; Shin-Yoon Kim
Journal:  Mol Cells       Date:  2010-03-12       Impact factor: 5.034

5.  Factor V Leiden and the prothrombin 20210A gene mutation and osteonecrosis of the knee.

Authors:  Anders Björkman; Isabella M Burtscher; Peter J Svensson; Andreas Hillarp; Jack Besjakov; Göran Benoni
Journal:  Arch Orthop Trauma Surg       Date:  2004-11-18       Impact factor: 3.067

6.  The C677T mutation in the methylenetetrahydrofolate reductase gene among the Indonesian Javanese population.

Authors:  Ahmad Hamim Sadewa; Retno Sutomo; Chiyo Hayashi; Myeong Jin Lee; Hitoshi Ayaki; Abdul Salam M Sofro; Masafumi Matsuo; Hisahide Nishio
Journal:  Kobe J Med Sci       Date:  2002-12

7.  A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity.

Authors:  I Weisberg; P Tran; B Christensen; S Sibani; R Rozen
Journal:  Mol Genet Metab       Date:  1998-07       Impact factor: 4.797

8.  Genetic background of nontraumatic osteonecrosis of the femoral head in the Korean population.

Authors:  Jun-Dong Chang; Mina Hur; Sang-Soo Lee; Je-Hyun Yoo; Kyu Man Lee
Journal:  Clin Orthop Relat Res       Date:  2008-03-19       Impact factor: 4.176

9.  Methylenetetrahydrofolate reductase gene polymorphism and glucocorticoid intake in children with ALL and aseptic osteonecrosis.

Authors:  B Bernbeck; C Mauz-Körholz; R B Zotz; U Göbel
Journal:  Klin Padiatr       Date:  2003 Nov-Dec       Impact factor: 1.349

10.  Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells.

Authors:  J C Tsai; H Wang; M A Perrella; M Yoshizumi; N E Sibinga; L C Tan; E Haber; T H Chang; R Schlegel; M E Lee
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

View more
  5 in total

1.  The effect of IL-4 and MTHFR gene variants in ankylosing spondylitis.

Authors:  S Yigit; A Inanir; S Tural; B Filiz; A Tekcan
Journal:  Z Rheumatol       Date:  2015-02       Impact factor: 1.372

2.  Osteonecrosis of the femoral head: genetic basis.

Authors:  Tracy Wang; Bouziane Azeddine; Wayne Mah; Edward J Harvey; David Rosenblatt; Chantal Séguin
Journal:  Int Orthop       Date:  2018-10-17       Impact factor: 3.075

3.  Association of MTHFR and TNF-α genes polymorphisms with susceptibility to Legg-Calve-Perthes disease in Iranian children: A case-control study.

Authors:  Mohammad Reza Azarpira; Mohammad Mahdi Ghilian; Mohammad Reza Sobhan; Masoud Mehdinezhad-Yazdi; Kazem Aghili; Seyed Mohsen Miresmaeili; Hossein Neamatzadeh
Journal:  J Orthop       Date:  2018-09-07

Review 4.  Genetic association between methylenetetrahydrofolate reductase gene polymorphism and risk of osteonecrosis of the femoral head.

Authors:  Wei Chai; Zhendong Zhang; Ming Ni; Peiliang Geng; Zijian Lian; Guoqiang Zhang; Lewis L Shi; Jiying Chen
Journal:  Biomed Res Int       Date:  2015-01-26       Impact factor: 3.411

Review 5.  Osteonecrosis of the Femoral Head in Patients with Hypercoagulability-From Pathophysiology to Therapeutic Implications.

Authors:  Elena Rezus; Bogdan Ionel Tamba; Minerva Codruta Badescu; Diana Popescu; Ioana Bratoiu; Ciprian Rezus
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.